Cargando…
Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells
“Off-targeting” and receptor density expressed at the target sites always compromise the efficacy of the nanoparticle-based drug delivery systems. In this study, we isolated different cell membranes and constructed cell membrane-cloaked biogenic nanoparticles for co-delivery of antitumor paclitaxel...
Autores principales: | Shair Mohammad, Imran, Chaurasiya, Birendra, Yang, Xuan, Lin, Chuchu, Rong, Hehui, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600481/ https://www.ncbi.nlm.nih.gov/pubmed/33050126 http://dx.doi.org/10.3390/pharmaceutics12100950 |
Ejemplares similares
-
Homotypic targeting of immunomodulatory nanoparticles for enhanced peripheral and central immunity
por: Shen, Yubo, et al.
Publicado: (2022) -
Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB)
por: Barros, Caio H. N., et al.
Publicado: (2018) -
Nanoformulation of Biogenic Cefotaxime-Conjugated-Silver Nanoparticles for Enhanced Antibacterial Efficacy Against Multidrug-Resistant Bacteria and Anticancer Studies
por: Halawani, Eman M, et al.
Publicado: (2020) -
Biogenic Silver Nanoparticles Strategically Combined With Origanum vulgare Derivatives: Antibacterial Mechanism of Action and Effect on Multidrug-Resistant Strains
por: Scandorieiro, Sara, et al.
Publicado: (2022) -
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma
por: Foglietta, Federica, et al.
Publicado: (2023)